Overview

Treatment of Nicotine Dependence and Acute Depression

Status:
Completed
Trial end date:
2007-09-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to assess the safety and feasibility of concurrent treatment of nicotine dependence (cigarette smoking) and acute depression. Participants who meet DSM-IV criteria for both nicotine dependence and acute major depression will be given pharmacological treatment for both disorders at the same time, along with a brief behavioral intervention for smoking cessation.
Phase:
Phase 4
Details
Lead Sponsor:
Stanford University
Collaborator:
GlaxoSmithKline
Treatments:
Bupropion
Nicotine